Advertisement
Accolade, Inc.

Accolade, Inc. (ACCD) Stock Overview

Explore Accolade, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

ACCDโ—NASDAQ
HealthcareMedical - Healthcare Information Services
$7.02
$0.00(0.00%)
U.S. Market is Open ยท 12:33
Advertisement

Accolade, Inc. (ACCD)

Meyka AI Score

Z

Key Financials

Market Cap575.6M
P/E Ratio-5.27
EPS (TTM)$-2.28
ROE-0.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ACCD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Accolade, Inc. (ACCD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.27 and a market capitalization of 575.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
2.03%
6-Month Change
97.19%
Year-to-Date (YTD) Change
105.26%
1-Year Change
-1.40%
3-Year Change
28.81%
5-Year Change
1176.36%
All-Time (Max) Change
1176.36%

Contact Information

206 926 8100
660 West Germantown Pike, Plymouth Meeting, PA, 19462

Company Facts

24,000 Employees
IPO DateJul 1, 2020
CountryUS

Frequently Asked Questions